What changed in Cardio Diagnostics Holdings, Inc.'s 2024 10-K compared to 2023?

Across the narrative sections we track, Cardio Diagnostics Holdings, Inc. (CDIO) added 0 paragraphs, removed 0, and edited 0 between the 2023 and 2024 10-K filings. The biggest movers are .

Where does this CDIO 10-K diff come from?

The source filings are Cardio Diagnostics Holdings, Inc.'s official 2023 and 2024 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

Cardio Diagnostics Holdings, Inc.CDIOEarnings & Financial Report

Nasdaq · Health Care · In Vitro & In Vivo Diagnostic Substances

Deep Analysis

Cardio Diagnostics Holdings, Inc. is a precision cardiovascular healthcare company that develops and commercializes integrated genetic and epigenetic diagnostic tests for early detection of coronary heart disease, heart failure, and other cardiovascular conditions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, focusing on delivering accessible, personalized cardiovascular care solutions.

What changed in Cardio Diagnostics Holdings, Inc.'s 10-K — 2023 vs 2024

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other CDIO 10-K year-over-year comparisons

CDIO 10-K 2024 vs 2025
CDIO 10-K 2022 vs 2023